ENHANZE ® drug delivery technology: a novel approach to subcutaneous administration using recombinant human hyaluronidase 20.
This article reviews pharmaceutical properties of rHuPH20, its current applications with approved therapeutics, and the potential for future developments.
PMID: 30744432 [PubMed - in process]
Source: Drug Delivery - Category: Drugs & Pharmacology Tags: Drug Deliv Source Type: research
More News: Drugs & Pharmacology | Herceptin | Primary Immunodeficiency Disease | Rituxan | Urography